Holen Sie sich die Stockscreener-App
1.82
11.31%
0.185
Handel nachbörslich:
2.02
0.20
+10.99%
Neumora Therapeutics Inc Aktie (NMRA) Neueste Nachrichten
Neumora outlines 2026 pipeline milestones for neuroscience programs By Investing.com - Investing.com Nigeria
Neumora gains after early-stage trial results for Alzheimer’s product - MSN
Positive Risk-Reward on Neumora as NMRA-511 Emerges as a Differentiated Therapy for Alzheimer’s Agitation, Supporting Buy Rating and $18 Target - TipRanks
Mizuho raises Neumora Therapeutics stock price target on positive trial data - Investing.com Canada
Neumora Therapeutics touts Phase 1B NMRA-511 gains in Alzheimer’s agitation, eyes higher doses - MarketBeat
Neumora shares climb after encouraging Phase 1b results for Alzheimer’s agitation therapy - MSN
Why Is Neumora Therapeutics Stock Gaining Monday?Neumora Therapeutics (NASDAQ:NMRA) - Benzinga
Neumora stock rises after positive Phase 1b data for Alzheimer’s agitation drug - Investing.com Canada
NMRA Surges On Clinically Meaningful Results In Phase 1 Alzheimer's Disease Agitation Study - Nasdaq
Neumora outlines 2026 pipeline milestones for neuroscience programs - Investing.com
Neumora posts trial results for Alzheimer’s drug (NMRA:NASDAQ) - Seeking Alpha
Neumora reports promising Phase 1b results in Alzheimer’s agitation - TipRanks
Neumora Therapeutics Announces Positive Phase 1b Study Results for NMRA-511 - TradingView — Track All Markets
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones - The Manila Times
Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation - The Manila Times
New Alzheimer’s treatment candidate eases agitation in early study - Stock Titan
10 Best New Penny Stocks to Invest In - Insider Monkey
RBC Sees Upside Potential in Neumora Therapeutics (NMRA) - Finviz
What analysts say about Neumora Therapeutics Inc stockMid Cap Growth Trends & Free Superior Trading Gains - earlytimes.in
Neumora stock rises after positive Phase 1b data for Alzheimer’s agitation drug By Investing.com - Investing.com South Africa
Momentum Shift: Will Neumora Therapeutics Inc. stock benefit from AI adoptionNew Guidance & Consistent Income Trade Recommendations - moha.gov.vn
Cash Runway Looks Solid, But Is Neumora's Pipeline Ready To Deliver? - RTTNews
Is Neumora Therapeutics Inc. stock resilient to inflation2025 Volatility Report & Fast Gaining Stock Reports - Улправда
Can Neumora Therapeutics Inc. stock beat market expectations this quarterQuarterly Profit Review & Risk Adjusted Buy/Sell Alerts - Улправда
Will Neumora Therapeutics Inc. stock benefit from AI adoptionOil Prices & Weekly Setup with High ROI Potential - Улправда
Analyst Calls: How Neumora Therapeutics Inc stock reacts to job market dataIPO Watch & Smart Swing Trading Techniques - moha.gov.vn
Is Neumora Therapeutics Inc. stock a defensive play in 2025July 2025 Pullbacks & AI Powered Market Entry Ideas - DonanımHaber
Will Neumora Therapeutics Inc. stock beat EPS estimates2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - DonanımHaber
Why Neumora Therapeutics Inc. stock could rally in 2025Stop Loss & Stock Portfolio Risk Management - Улправда
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Neumora Therapeutics Earnings Notes - Trefis
Neumora cut to Hold at Stifel after J&J’s VENTURA exit - MSN
MACD Signal: Can Neumora Therapeutics Inc stock beat market expectations this quarterJuly 2025 Update & Verified Chart Pattern Signals - BỘ NỘI VỤ
Neumora Therapeutics upgraded to Outperform from Sector Perform at RBC Capital - MSN
Neumora upgraded at RBC Capital Markets on obesity, Parkinson's asset - MSN
Can Neumora Therapeutics Inc. stock weather global recession2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
How Neumora Therapeutics Inc. stock reacts to job market dataQuarterly Trade Review & Free Accurate Trade Setup Notifications - Newser
Is Neumora Therapeutics Inc. stock attractive for ETFsPortfolio Growth Summary & Technical Buy Zone Confirmation - Newser
What momentum indicators show for Neumora Therapeutics Inc. stockGold Moves & Safe Capital Investment Plans - Newser
Neumora Therapeutics (NMRA) Stock Analysis Report | Financials & Insights - Benzinga
Neumora Therapeutics stock rating upgraded by RBC Capital on NLRP3 potential - Investing.com Canada
Neumora Therapeutics Shares Rise After RBC Upgrade - marketscreener.com
Neumora upgraded at RBC Capital Markets on obesity, Parkinson's asset (NMRA:NASDAQ) - Seeking Alpha
Analyst Sees Value In Neumora's Expanding Obesity And Metabolic Pipeline - Benzinga
This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
RBC Capital Upgrades Neumora Therapeutics (NMRA) - Nasdaq
RBC Upgrades Neumora Therapeutics to Outperform From Sector Perform, Raises Price Target to $7 From $4, Keeps Speculative Risk - marketscreener.com
What drives Neumora Therapeutics Inc stock priceIPO Market Watch & Outstanding Portfolio Tips - earlytimes.in
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):